Last reviewed · How we verify
NCT06727500: HIIT-PRO-kids
Effects of HIIT and Concurrent HITT/Plyometric Training on Muscle-tendon Structure, Function and Metabolism in Pediatric Population With Obesity at Different Biological Maturation States (HIIT-PRO Kids).
NA trial testing HIIT plus plyometric training in Pediatric Obesity in 40 participants. Currently enrolling.
1 August 2025
Quick facts
| Lead sponsor | Universidad Nacional Andres Bello |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 April 2025 |
| Primary completion | 1 August 2025 |
| Estimated completion | 1 September 2026 |
| Sites | 1 location across Chile |
Drugs / interventions tested
- HIIT plus plyometric training
- HIIT
Conditions studied
- Pediatric Obesity — all drugs for Pediatric Obesity →
- Training Effectiveness — all drugs for Training Effectiveness →
Sponsor
Universidad Nacional Andres Bello
Who can join
Adults 7 to 17, any sex, with Pediatric Obesity or Training Effectiveness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The randomized controlled trial will compare the effects of a High-intensity interval training (HIIT) protocol versus a HIIT plus plyometric training in the muscle-tendon structure function and metabolism of the pediatric population with obesity at different biological maturational stages (pre-to-age peak velocity \[APHV\] and post-APHV). Both groups perform baseline evaluations of the main and secondary outcomes and receive the intervention for twelve weeks, three times per week. Once the interventions are completed, the participants undergo the same evaluations they performed at baseline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06727500
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric Obesity
Currently open trials in the same condition.
- NCT06565455 — Growing Healthy Children and Families in Rural Arkansas · NA · recruiting
- NCT07342855 — Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program · NA · recruiting
- NCT07095166 — Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME) · NA · recruiting
- NCT07229508 — Developmental Trajectories of Reinforcer Pathology and Childhood Obesity · recruiting
- NCT06572345 — Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study · NA · recruiting
Other Universidad Nacional Andres Bello trials
Trials by the same sponsor.
- NCT06725901 — Pediatric Neurogenetic Diagnosis Support Platform · NA · recruiting
- NCT06428032 — Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy · NA · recruiting
- NCT06077123 — Telemonitoring Platforms and Chemotherapy-Associated Toxicity · NA · recruiting
- NCT06895850 — Eccentric Cycling Vs. Standard Rehabilitation for Post-ICU Recovery in COVID-19 Survivors · NA · completed
- NCT04489446 — Sildenafil in COVID-19 · Phase 1, PHASE2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06727500 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Nacional Andres Bello
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06727500.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing